LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 14, 2006--Predix Pharmaceuticals announced today that Michael G. Kauffman, M.D., Ph.D., President and CEO of Predix, has been invited to participate in a Focus Session entitled “CNS Disorders: Alzheimer’s and Parkinson’s - What is on the Horizon?” at the 8th Annual BIO CEO & Investor Conference 2006 at the Waldorf-Astoria in New York City, New York, on Wednesday, February 15, 2006 at 8:30 a.m. (EST). The focus session will be webcast approximately 12 hours after the presentation and can be accessed by visiting the following link, http://ceo.bio.org/opencms/ceo/2006/index.jsp.
